Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients

American Journal of Clinical Nutrition

Volumn 80, Issue 2, 2004, Pages 299-307

  Kalantar Zadeh, Kamyar ^a,b,c   Block, Gladys ^c   McAllister, Charles J ^d   Humphreys, Michael H ^e   Kopple, Joel D ^a,b,f  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DAVITA INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anorexia; Appetite; Dialysis; Inflammation; Outcome; Protein energy malnutrition

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANEMIA; ANOREXIA; APPETITE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFLAMMATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALNUTRITION; MORTALITY; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUALITY OF LIFE; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; FEMALE; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDY; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; STATISTICS;

ADULT; ANALYSIS OF VARIANCE; ANEMIA; ANOREXIA; APPETITE; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 4344560597     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.2.299     Document Type: Conference Paper

References (59)

1. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 2001;19:143-51.
2. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 2001;38:1343-50.
3. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-63.
4. Castaneda C, Gordon PL, Parker RC, et al. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004;43:607-16.
5. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42:864-81.
6. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953-60.
7. Dwyer JT, Larive B, Leung J, et al. Nutritional status affects quality of life in Hemodialysis (HEMO) Study patients at baseline. J Ren Nutr 2002;12:213-23.
8. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001;12:2797-806.
9. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2000;35:293-300.
10. Yeh S, Wu SY, Levine DM, et al. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 2000;4:246-51.
11. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001;37:564-72.
12. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001;16(suppl):36-40.
13. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003;42:761-73.
14. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999;56:1136-48.
15. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl 2002;May:103-8.
16. Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994;24:1002-9.
17. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
18. Kensit M. Appetite disturbances in dialysis patients. J Am Assoc Nephrol Nurses Tech 1979;6:194-9.
19. Ginsberg N, Fishbane D, Lynn R. The effect of improved dialytic efficiencies on measures of appetite in peritoneal dialysis patients. J Renal Nutr 1996;6:217-21.
20. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001;37:337-42.
21. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000;108:609-13.
22. Leung J, Dwyer J, Miller J, Patrick SW, Rocco M, Uhlin L. The role of the dietitian in a multicenter clinical trial of dialysis therapy: the Hemodialysis (HEMO) Study. J Ren Nutr 2001;11:101-8.
23. Rocco MV, Dwyer JT, Larive B, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients. Kidney Int 2004;65:2321-34.
24. Kalantar-Zadeh K, Kleiner M, Dunne E, et al. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 1998;31:263-72.
25. Nelson EE, Hong CD, Pesce AL, Singh S, Pollak VE. Anthropometric norms for the dialysis population. Am J Kidney Dis 1990;16:32-7.
26. Williams AJ, McArley A. Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 1999;9:157-62.
27. Kalantar-Zadeh K, Block G, Kelly MP, Schroepfer C, Rodriguez RA, Humphreys MH. Near infra-red interactance for longitudinal assessment of nutrition in dialysis patients. J Ren Nutr 2001;11:23-31.
28. Kalantar-Zadeh K, Dunne E, Nixon K, et al. Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 1999;14:169-75.
29. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
30. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 2003;13:15-25.
31. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
32. Erbagci AB, Tarakcioglu M, Aksoy M, et al. Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 2002;57:197-204.
33. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002;17:1684-8.
34. Stenvinkel P, Heimburger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002;39:274-82.
35. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of host response. Annu Rev Immunol 1989;7:625-55.
36. United States Renal Data System. Bethesda, MD: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health, 1999.
37. United States Renal Data System. Bethesda, MD: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health, 1998.
38. Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial 2001;14:252-6.
39. National Kidney Foundation I, Kidney-Dialysis Outcome Quality Initiative. K/DOQI clinical practice guidelines: anemia of chronic kidney disease. Am J Kidney Dis 2001;37(suppl):S182-238.
40. Bergstrom J. Regulation of appetite in chronic renal failure. Miner Electrolyte Metab 1999;25:291-7.
41. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995;26:353-61.
42. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998;54:236-44.
43. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001;12:1549-57.
44. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 2002;12:17-31.
45. Lowbeer C, Stenvinkel P, Pecoits-Filho R, et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003;253:153-60.
46. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
47. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-14.
48. Espat NJ, Copeland EM, Moldawr LL. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol 1994;3:255-62.
49. McCarthy DO. Cytokines and the anorexia of infection: potential mechanisms and treatments. Biol Res Nurs 2000;1:287-98.
50. McCarthy DO. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 2000;23:222-8.
51. Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 1998;32:834-41.
52. Ritz E, Vallance P, Nowicki M. The effect of malnutrition on cardiovascular mortality in dialysis patients: is L-arginine the answer? Nephrol Dial Transplant 1994;9:129-30.
53. Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality. Peril Dial Int 1999;19:S309-14.
54. Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002;40:307-14.
55. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000;58:346-52.
56. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha, and their specific inhibitors in undialyzed patients with chronic renal failure. Kidney Int 1994;45:890-6.
57. Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 1998;13:1476-83.
58. Stenvinkel P, Barany P. Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 2002;17(suppl):32-7.
59. Mingardi G. Quality of life and end stage renal disease therapeutic programs. DIA-QOL Group. Dialysis quality of life. Int J Artif Organs 1998;21:741-7.